The Pharmacology of Bacterial Persistence: From Antibiotic Tolerance to Antimicrobial Resistance

Maria Cristina Caroleo1,2, Maria Pisano2, Erika Cione3

  • 1CRUISE Research Center, Science of Health Department, University Magna Graecia, 88100 Catanzaro, Italy.

Insights

Bacterial persister cells, though susceptible to antibiotics, can cause persistent infections. New strategies should focus on preventing persister cells to reduce relapses and the development of antimicrobial resistance (AMR).

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Persistent infections involve recurrent treatment failures and relapses, unexplained by standard antibiotic susceptibility testing.
  • Bacterial persister cells are genetically susceptible but phenotypically tolerant subpopulations that survive antibiotic exposure via reversible physiological adaptations.
  • Conventional resistance paradigms do not fully account for the clinical reality of persistent infections.

Purpose of the Study:

  • To propose a pharmacological framework linking antimicrobial exposure, bacterial tolerance, persistence, relapse, and antimicrobial resistance (AMR).
  • To operationalize persistence prevention exposure (PPE) using various antimicrobial exposure metrics.
  • To advocate for a shift in antimicrobial therapy models.

Main Methods:

  • A structured narrative review of scientific literature and surveillance data.
  • Utilized databases such as PubMed/MEDLINE, ClinicalTrials.gov, CDC, and WHO/GLASS.
  • Followed the Scale for the Assessment of Narrative Review Articles (SANRA) framework.

Main Results:

  • Bacterial resistance, tolerance, and persistence are pharmacologically distinct phenotypes.
  • Persistence occurs without an elevated minimum inhibitory concentration (MIC) and is influenced by factors like antimicrobial exposure, target penetration, biofilms, intracellular location, and host stress.
  • Introduced concepts like persistence prevention exposure (PPE), minimum duration for killing (MDK), persister fraction, and minimum biofilm eradication concentration (MBEC).

Conclusions:

  • Antimicrobial therapy must evolve beyond MIC suppression to include prevention and eradication of persister cell reservoirs.
  • Preventing bacterial persistence may decrease infection relapse rates and reduce the need for repeated antibiotic courses.
  • Targeting bacterial persistence could mitigate the evolutionary pathways leading to stable antimicrobial resistance (AMR).

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...